Fanconi Anemia

Hematology/Oncology Clinics of North America

Volumn 23, Issue 2, 2009, Pages 193-214

  Green, Allison M ^a   Kupfer, Gary M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow failure; BRCA1 2; Cytokines; DNA damage and repair; Fanconi anemia; Genomic instability; Monobiquitylation; Oxidative stress

Indexed keywords

BRCA2 PROTEIN; CYCLOPHOSPHAMIDE; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; CELL FUNCTION; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; CROSS LINKING; DNA REPAIR; FANCONI ANEMIA; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GRAFT VERSUS HOST REACTION; HUMAN; LOW BIRTH WEIGHT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN SYNTHESIS; REVIEW; SENSITIVITY ANALYSIS; SKELETON MALFORMATION; SKIN DISCOLORATION; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ANIMALS; DNA DAMAGE; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENOMIC INSTABILITY; HUMANS; OXIDATIVE STRESS; STEM CELL TRANSPLANTATION;

EID: 62649172691     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.01.008     Document Type: Review

References (130)

1. Bagby G.C., and Alter B.P. Fanconi anemia. Semin Hematol 43 3 (2006) 147-156
2. D'Andrea A.D., Dahl N., Guinan E.C., et al. Marrow failure. Hematology Am Soc Hematol Educ Program (2002) 58-72
3. Tischkowitz M., and Dokal I. Fanconi anaemia and leukemia: clinical and molecular aspects. Br J Haematol 126 2 (2004) 176-191
4. Alter B.P. Fanconi's anemia, transplantation, and cancer. Pediatr Transplant 9 Suppl 7 (2005) 81-86
5. Lustig J.P., Lugassy G., Neder A., et al. Head and neck carcinoma in Fanconi's anaemia: report of a case and review of the literature. Eur J Cancer B Oral Oncol 31B 1 (1995) 68-72
6. Lowy D.R., and Gillison M.L. A new link between Fanconi anemia and human papillomavirus-associated malignancies. J Natl Cancer Inst 95 22 (2003) 1648-1650
7. Masserot C., Peffault de Latour R., Rocha V., et al. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer 113 (2008) 3315-3322
8. Socie G., Scieux C., Gluckman E., et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation 66 5 (1998) 667-670
9. Auerbach A.D. Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet (2003) Chapter 8: Unit 8.7
10. Hirschhorn R. In vivo reversion to normal of inherited mutations in humans. J Med Genet 40 10 (2003) 721-728
11. Gregory Jr. J.J., Wagner J.E., Verlander P.E., et al. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci U S A 98 5 (2001) 2532-2537
12. Soulier J., Leblanc T., Larghero J., et al. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood 105 3 (2005) 1329-1336
13. Lo Ten Foe J.R., Kwee M.L., Rooimans M.A., et al. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 5 3 (1997) 137-148
14. Xie Y., de Winter J.P., Waisfisz Q., et al. Aberrant Fanconi anemia protein profiles in acute myeloid leukemia cells. Br J Haematol 111 4 (2000) 1057-1064
15. Velez-Ruelas M.A., Martinez-Jaramillo G., Arana-Trejo R.M., et al. Hematopoietic changes during progression from Fanconi anemia into acute myeloid leukemia: case report and brief review of the literature. Hematology 11 5 (2006) 331-334
16. Alter B.P., Rosenberg P.S., Brody L.C., et al. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J Med Genet 44 1 (2007) 1-9
17. Meyer S., Fergusson W.D., Whetton A.D., et al. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption. Genes Chromosomes Cancer 46 4 (2007) 359-372
18. Gillio A.P., Verlander P.C., Batish S.D., et al. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 90 1 (1997) 105-110
19. Auerbach A.D. Fanconi anemia: genetic testing in Ashkenazi Jews. Genet Test 1 1 (1997) 27-33
20. Farzin A., Davies S.M., Smith F.O., et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anemia: an update of the Cincinnati Children's experience. Br J Haematol 136 4 (2007) 633-640
21. Pasquini R., Carreras J., Pasquini M.C., et al. HLA-matched sibling hematopoietic stem cell transplantation for Fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transplant 14 10 (2008) 1141-1147
22. Gluckman E., and Wagner J.E. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndromes. Bone Marrow Transplant 41 2 (2008) 127-132
23. Brown J.A., and Boussiotis V.A. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 127 3 (2008) 286-297
24. Burt R.K., Loh Y., Pearce W., et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299 8 (2008) 925-936
25. Craddock C.F. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML. Bone Marrow Transplant 41 5 (2008) 415-423
26. Brunstein C.G., Baker K.S., and Wagner J.E. Umbilical cord blood transplantation for myeloid malignancies. Curr Opin Hematol 14 2 (2007) 162-169
27. Chaudhury S., Auerbach A.D., Kernan N.A., et al. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol 140 6 (2008) 644-655
28. Gluckman E., Rocha V., Ionescu I., et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 13 9 (2007) 1073-1082
29. Bitan M., Or R., Shapira M.Y., et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 12 7 (2006) 712-718
30. Huck K., Hanenberg H., Nurnberger W., et al. Favourable long-term outcome after matched sibling transplantation for Fanconi-anemia (FA) and in vivo T-cell depletion. Klin Padiatr 220 3 (2008) 147-152
31. Balci Y.I., Akdemir Y., Gumruk F., et al. CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for Fanconi anemia. Pediatr Blood Cancer 50 5 (2008) 1065-1067
32. Ayas M., Al-Jefri A., Al-Seraihi A., et al. Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: update on the Saudi experience. Bone Marrow Transplant. 41 3 (2008) 261-265
33. Millen F.J., Rainey M.G., Hows J.M., et al. Oral squamous cell carcinoma after allogeneic bone marrow transplantation for Fanconi anaemia. Br J Haematol 99 2 (1997) 410-414
34. Rosenberg P.S., Alter B.P., Socie G., et al. Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies. Biol Blood Marrow Transplant 11 9 (2005) 672-679
35. Croop J.M. Gene therapy for Fanconi anemia. Curr Hematol Rep 2 4 (2003) 335-340
36. Yamada K., Ramezani A., Hawley R.G., et al. Phenotype correction of Fanconi anemia group a hematopoietic stem cells using lentiviral vector. Mol Ther 8 4 (2003) 600-610
37. Kelly P.F., Radtke S., von Kalle C., et al. Stem cell collection and gene transfer in Fanconi anemia. Mol Ther 15 1 (2007) 211-219
38. Si Y., Ciccone S., Yang F.C., et al. Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice. Blood 108 13 (2006) 4283-4287
39. Ozenne V., Paradis V., Vullierme M.P., et al. Liver tumours in patients with Fanconi anaemia: a report of three cases. Eur J Gastroenterol Hepatol 20 10 (2008) 1036-1039
40. Velazquez I., and Alter B.P. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 77 3 (2004) 257-267
41. Akkari Y.M., Bateman R.L., Reifsteck C.A., et al. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol Genet Metab 74 4 (2001) 403-412
42. Meetei A.R., Medhurst A.L., Ling C., et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 37 9 (2005) 958-963
43. Lightfoot J., Alon N., Bosnoyan-Collins L., et al. Characterization of regions functional in the nuclear localization of the Fanconi anemia group a protein. Hum Mol Genet 8 6 (1999) 1007-1015
44. Meetei A.R., Levitus M., Xue Y., et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 36 11 (2004) 1219-1224
45. de Winter J.P., Leveille F., van Berkel C.G.M., et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet 67 5 (2000) 1306-1308
46. Meetei A.R., de Winter J.P., Medhurst A.L., et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 35 2 (2003) 165-170
47. Gurtan A.M., Stuckert P., and D'Andrea A.D. The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly. J Biol Chem 281 16 (2006) 10806-10905
48. Kim J.M., Kee Y., Gurtan A., et al. Cell cycle dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood 111 10 (2008) 5215-5222
49. Komori K., Fujikane R., Shinagawa H., et al. Novel endonuclease in Archaea cleaving DNA with various branched structure. Genes Genet Syst 77 4 (2002) 227-241
50. Gari K., Decaillet C., Stasiak A.Z., et al. The Fanconi anemia protein FANCM can promote branch migration of holliday junctions and replication forks. Mol Cell 29 1 (2008) 141-148
51. Yamashita T., Kupfer G.M., Naf D., et al. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc Natl Acad Sci U S A 95 22 (1998) 13085-13090
52. Qiao F., Mi J., Wilson J.B., et al. Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway. J Biol Chem 279 44 (2004) 46035-46045
53. Mi J., Qiao F., Wilson J.B., et al. FANCG is phosphorylated at serines 383 and 387 during mitosis. Mol Cell Biol 24 19 (2004) 8576-8585
54. Medhurst A.L., El Houari L., Steltenpool J., et al. Evidence for subcomplexes in the Fanconi anemia pathway. Blood 108 6 (2006) 2072-2080
55. Folias A., Matkovic M., Bruun D., et al. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum Mol Genet 11 21 (2002) 2591-2597
56. Hussain S., Witt E., Huber P.A.J., et al. Direct interaction of the Fanconi anemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet 12 19 (2003) 2503-2510
57. Gordon S.M., and Buchwald M. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3- hybrid systems. Blood 102 1 (2003) 136-141
58. Pace P., Johnson M., Tan W.M., et al. FANCE: the link between Fanconi anemia complex assembly and activity. EMBO J 21 13 (2002) 3414-3423
59. Garcia-Higuera I., Taniguchi T., Ganesan S., et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7 (2001) 249-262
60. Taniguchi T., Garcia-Higuera I., Andreassen P.R., et al. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100 (2002) 2414-2420
61. Wang X., Andreassen P.R., and D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 24 13 (2004) 5850-5862
62. Smogorzewska A., Matsuoka S., Vinciguerra P., et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129 2 (2007) 289-301
63. Sims A.E., Spiteri E., Sims III R.J., et al. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat Struct Mol Biol 14 6 (2007) 564-567
64. Dorsman J.C., Levitus M., Rockx D., et al. Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol 29 3 (2007) 211-218
65. Levitus M., Rooimans M.A., Steltenpool J., et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103 7 (2004) 2498-2503
66. Taniguchi T., Garcia-Higuera I., Xu B., et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109 4 (2002) 459-472
67. Ishiai M., Kitao H., Smogorzewska A., et al. FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat Struct Mol Biol 15 11 (2008) 1138-1146
68. Howlett N.G., Taniguchi T., Olson S., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 5581 (2002) 606-609
69. Godthelp B.C., Wiegant W.W., Waisfisz Q., et al. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat Res 594 1-2 (2006) 39-48
70. Shinohara A., Ogawa H., and Ogawa T. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69 3 (1992) 457-470
71. Wong A.K.C., Pero R., Ormonde P.A., et al. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 272 51 (1997) 31941-31944
72. Yang H., Jeffrey P.D., Miller J., et al. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297 5588 (2002) 1837-1848
73. Li J., Zou C., Bai Y., et al. DSS1 is required for the stability of BRCA2. Oncogene 25 8 (2006) 1186-1194
74. Levitus M., Waisfisz Q., Godthelp B.C., et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 37 9 (2005) 934-935
75. Levran O., Attwooll C., Henry R.T., et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37 9 (2005) 931-933
76. Litman R., Peng M., Jin Z., et al. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8 3 (2005) 255-265
77. Cantor S.B., Bell D.W., Ganesan S., et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to Its DNA repair function. Cell 105 1 (2001) 149-160
78. Yu X., Chini C.C.S., He M., et al. The BRCT domain is a phospho-protein binding domain. Science 302 5645 (2003) 639-642
79. Wu Y., Shin-ya K., and Brosh Jr. R.M. FANCJ helicase defective in Fanconi anemia and breast cancer unwinds G-quadruplex DNA to defend genomic instability. Mol Cell Biol 28 12 (2008) 4116-4128
80. Xia B., Dorsman J.C., Ameziane N., et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39 2 (2007) 159-161
81. Reid S., Schindler D., Hanenberg H., et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39 2 (2007) 162-164
82. Dronkert M.L., and Kanaar R. Repair of DNA interstrand cross-links. Mutat Res 486 4 (2001) 217-247
83. Nojima K., Hochegger H., Saberi A., et al. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res 65 24 (2005) 11704-11711
84. Shin D.S., Chahwan C., Huffman J.L., et al. Structure and function of the double strand break repair machinery. DNA Repair (Amst) 4 2 (2004) 91-98
85. Sharan S.K., Morimatsu M., Albrecht U., et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51in mice lacking Brca2. Nature 386 6627 (1997) 804-810
86. Scully R., Xie A., and Nagaraju G. Molecular functions of BRCA1 in the DNA damage response. Cancer Biol Ther 3 6 (2004) 521-527
87. Rajan J.V., Wang S.T., Marquis S.T., et al. BRCA2 is coordinately regulated with BRCA1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci 93 23 (1996) 13078-13083
88. Scully R., Chen J., Plug A., et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88 2 (1997) 265-275
89. Chen J., Silver D.P., Walpita D., et al. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell 2 3 (1998) 317-328
90. Seki M., Tada S., and Enomoto T. Function of recQ family helicase in genome stability. Subcell Biochem 40 (2006) 49-73
91. Park W.H., Margossian S., Horwitz A.A., et al. Direct DNA binding activity of the Fanconi anemia D2 protein. J Biol Chem 280 25 (2005) 23593-23598
92. Meetei A.R., Sechi S., Wallisch M., et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol 23 10 (2003) 3417-3426
93. Pichierri P., Franchitto A., and Rosselli F. BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. EMBO 23 15 (2004) 3154-3163
94. Kinner A., Wu W., Staudt C., et al. Gamma-H2AX in recognition and signaling of DNA double strand breaks in the context of chromatin. Nucleic Acids Res 36 17 (2008) 5678-5694
95. Bogliolo M., Lyakhovich A., Callen E., et al. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO 26 5 (2007) 1340-1351
96. McCulloch S.D., and Kunkel T.A. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res 18 1 (2008) 148-161
97. Andersen P.L., Xu F., and Xiao W. Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA. Cell Res 18 1 (2008) 162-173
98. Hussain S., Wilson J.B., Medhurst A.L., et al. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum Mol Genet 13 12 (2004) 1241-1248
99. Prakash S., Johnson R.E., and Prakash L. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem 74 (2005) 317-353
100. Niedzwiedz W., Mosedale G., Johnson M., et al. The Fanconi anemia gene FANCC promotes homologous recombination and error prone DNA repair. Mol Cell 15 (2004) 607-620
101. Mirchandani K.D., McCaffrey R.M., and D'Andrea A.D. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair. 7 (2008) 902-911
102. Fujiwara T., Saito A., Suzuki M., et al. Identification and chromosomal assignment of USP1, a novel gene encoding a human ubiquitin-specific protease. Genomics 54 1 (1998) 155-158
103. Nijman S.M., Huang T.T., Dirac A.M., et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell 17 3 (2005) 331-339
104. Huang T.T., Nijman S.M., Mirchandani K.D., et al. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol 8 4 (2006) 339-347
105. Oestergaard V.H., Langevin F., Kuiken H.J., et al. Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol Cell 28 5 (2007) 798-809
106. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signaling and cancer. Mol Cell Biol 9 (2008) 759-769
107. Djuzenova C., Flentje M., and Plowman P.N. Radiation response in vitro of fibroblasts from a Fanconi anemia patient with marked clinical radiosensitivity. Strahlenther Onkol 180 12 (2004) 789-797
108. Cimprich K.A., and Cortez D. ATR: an essential regulator of genome integrity. Mol Cell Biol 9 (2008) 616-627
109. Pichierri P., and Rosselli F. The DNA crosslink induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO 23 (2004) 1178-1187
110. Andreassen P.R., D'Andrea A.D., and Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA damage response. Genes Dev 18 (2004) 1958-1963
111. Ho G.P., Margossian S., Taniguchi T., et al. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol Cell Biol 26 18 (2006) 7005-7015
112. Wilson J.B., Yamamoto K., Marriott A.S., et al. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Oncogene 27 (2008) 3641-3652
113. Collis SJ, Ciccia A, Deans AJ, et al. FANCM and FAAP24 function in ATR mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol Cell 32:313-24.
114. Enders G.H. Expanded roles for Chk1 in genome maintenance. J Biol Chem 283 26 (2008) 17749-17752
115. Wang X., Kennedy R.D., Ray K., et al. Chk1 mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol Cell Biol 27 8 (2007) 3098-3108
116. Gordon-Smith E.C., and Rutherford T.R. Fanconi anemia: constitutional, familial aplastic anemia. Baillieres Clin Haematol 2 (1989) 139-152
117. Bornman L., Baladi S., Richard M.J., et al. Differential regulation and expression of stress proteins and ferritin in human monocytes. J Cell Physiol 178 (1999) 1-8
118. Kovacic P., and Jacintho J.D. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem 8 (2001) 773-796
119. Evans L.M., Davies J.S., Anderson R.A., et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 142 (2000) 254-262
120. Memoli S., Napolitanto A., D'Ischia M., et al. Diffusible melanin-related metabolites are potent inhibitors of lipid peroxidation. Biochim Biophys Acta 1346 (1997) 61-68
121. Wells P.G., Kim P.M., Laposa R.R., et al. Oxidative damage in chemical teratogenesis. Mutat Res 396 (1997) 65-78
122. Kruyt F.A., Hoshino T., Liu J.M., et al. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 92 (1998) 3050-3056
123. Cumming R.C., Lightfoot J., Beard K., et al. Fanconi anemia fropu C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 7 (2001) 814-820
124. Zanier R., Briot D., Villard J.A., et al. Fanconi anemia C gene product regulates the expression of genes involved in differentiation and inflammation. Oncogene 23 (2004) 5004-5013
125. Futaki M., Igarashi T., Watanabe S., et al. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 23 (2002) 67-72
126. Park S., Ciccone S.L.M., Beck B.D., et al. Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins. J Biol Chem 279 29 (2004) 30053-30059
127. Fagerlie S., Lensch M.W., Pang Q., et al. The Fanconi anemia group C gene product: signaling functions in hematopoietic cells. Exp Hematol 29 (2001) 1371-1381
128. Li J., Sejas D.P., Zhang X., et al. TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. J Clin Invest 117 11 (2007) 3283-3295
129. Pang Q., Fagerlie S., Christianson T.A., et al. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Mol Cell Biol 20 13 (2000) 4724-4735
130. Pang Q., Keeble W., Christianson T.A., et al. FANCC interacts with Hsp70 to protect hematopoietic cells from IFNγ/TNF-α mediated cytotoxicity. EMBO 20 16 (2001) 4478-4489